Pangenomic Health (NARA.CN) traded up 6.25 % during a 24 hours period ending at 09:25 PM Central Europe on Monday 26th. One Pangenomic Health stock can currently be bought for about CAD 0.17 on popular exchanges. Current supply of Pangenomic Health stocks is 25.7 mn. Pangenomic Health has a current market capitalization of CAD 4.4 mn and approximately CAD 170.34 worth of Pangenomic Health was traded on exchanges in the last 24 hours. Since last month end, Pangenomic Health has traded -32 % down. Simple moving average of last 200 days is at CAD 0.37. The highest price of past 52 weeks was recorded at CAD 1.23 on 11/03/2025. 52 weeks low was at CAD 0.16 on 10/22/2026.

Here is how related stocks have performed in the past 24 hours:

  • Bedford Metals (BFM.V) traded flat 0 % and now trades at CAD 0.06. Current market capitalisation for Bedford Metals is CAD 5.2 mn.

  • Imagine Lithium (ILI.V) traded flat 0 % and now trades at CAD 0.02. Imagine Lithium has a market capitalisation of CAD 5.2 mn.

  • Omega Pacific (OMGA.CN) traded flat 0 % and now trades at CAD 0.1. Current market capitalisation for Omega Pacific is CAD 5.2 mn.

  • North Atlantic Titanium (NATO.CN) traded down -12.5 % and now trades at CAD 0.07. Current market capitalisation for North Atlantic Titanium is CAD 5.2 mn.

  • Simply Solventless Concentra (HASH.V) traded flat 0 % and now trades at CAD 0.05. Current market capitalisation for Simply Solventless Concentra is CAD 5.2 mn.

About Pangenomic Health

PanGenomic Health Inc. is a Canadian biotechnology company that specializes in the development of novel diagnostic tools and techniques for detecting various diseases, including cancer. The company’s mission is to revolutionize the diagnostic industry by providing accurate, rapid, and cost-effective solutions for healthcare providers and patients. PanGenomic Health Inc.’s innovative approach to disease detection has led to the development of proprietary diagnostic assays that can identify specific genetic markers associated with various diseases. By focusing on personalized healthcare, the company aims to create a more informed and targeted approach to disease management.